| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 12 |
| 1 | BLEOMYCIN SULFATE | 9 |
| 2 | CLOZAPINE | 8 |
| 3 | ETOPOSIDE | 8 |
| 4 | ADALIMUMAB | 7 |
| 5 | AZATHIOPRINE | 7 |
| 6 | ALLOPURINOL | 6 |
| 7 | METHYLPREDNISOLONE | 6 |
| 8 | SPIRONOLACTONE | 6 |
| 9 | BLEOMYCIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOMYCIN | 1 | 0.0009 |
| 1 | BLEOMYCIN SULFATE | 9 | 0.0009 |
| 2 | SOTALOL HYDROCHLORIDE TABLES AF | 1 | 0.0004 |
| 3 | SOTALOL HYDROCHLORIDE TABLETS AF | 1 | 0.0004 |
| 4 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| 5 | CAPIVASERTIB | 1 | 0.0003 |
| 6 | CEFAZOLIN SODIUM | 2 | 0.0002 |
| 7 | CISPLATIN | 12 | 0.0002 |
| 8 | DICLOFENAC SODIUM AND MISOPROSTOL | 1 | 0.0002 |
| 9 | MERCAPTOPURINE | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 14 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | Atypical Antipsychotic [EPC] | 8 |
| 3 | Topoisomerase Inhibitor [EPC] | 8 |
| 4 | Purine Antimetabolite [EPC] | 7 |
| 5 | Aldosterone Antagonist [EPC] | 6 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 6 |
| 7 | Estrogen [EPC] | 5 |
| 8 | Alkylating Drug [EPC] | 4 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 1 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 4 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 14 | 0.0001 |
| 6 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 7 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 8 | Aldosterone Antagonist [EPC] | 6 | 0.0000 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 6 | 0.0000 |